The global CPAP market is forecast to exhibit significant growth between 2025 and 2035, reaching a market size of USD 561.8 million in 2025 and USD 1 billion by 2035.
The industry will expand at a CAGR of 6.0%, propelled by the increasing prevalence of obstructive sleep apnea (OSA), heightened awareness of sleep-related health risks, and the rising preference for home-based respiratory therapies.
Product-wise, CPAP devices are set to dominate the market landscape with a projected 65% share in 2025. These devices are considered essential for treating sleep apnea as they deliver a constant airflow to prevent airway collapse during sleep. The demand is further strengthened by an aging global population and the growing incidence of lifestyle diseases such as obesity, a key risk factor for OSA.
By operation type, automatic CPAP (APAP) systems are forecast to secure a substantial 70% market share by 2025. Their ability to self-adjust air pressure based on the patient’s breathing patterns offers superior comfort and enhances therapy compliance, making them the preferred choice among healthcare providers and patients alike. Manufacturers are increasingly integrating features such as remote monitoring, cloud connectivity, and AI-driven adjustments to improve user adherence.
Key players shaping the competitive landscape include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, DeVilbiss Healthcare LLC, and BMC Medical Co., Ltd. These companies are prioritizing product miniaturization, noise reduction, and mobile-friendly designs to cater to the evolving consumer needs of portability and convenience.
In late January 2025, ResMed officially reported a 10% year-over-year increase in organic sales for its CPAP devices and masks, reaching USD 1.28 billion for the quarter ended December 31, 2024. Despite this growth, the company’s shares fell by 8.3%, largely due to slower sales performance in markets such as Europe and Asia and rising investor concerns about the long-term impact of GLP-1 obesity drugs on CPAP therapy demand.
However, ResMed’s management clarified that these medications could complement rather than disrupt CPAP usage. This development was reported by Investor’s Business Daily in its article titled “ResMed Tumbles As Organic Sales Growth Steps Down. Will These 'Mega Trends' Save It?” published in January 2025.
Despite growth opportunities, challenges such as high device costs, therapy discomfort, and maintenance issues persist. However, favorable reimbursement policies in North America and Europe and increased healthcare expenditure in Asia-Pacific regions are expected to offset these barriers, ensuring market expansion.
| Attribute | Details |
|---|---|
| Market Size (2025) | USD 561.8 million |
| Market Size (2035) | USD 1 billion |
| CAGR (2025 to 2035) | 6.0% |
In 2025, CPAP Devices are expected to dominate the market with a 65% share, driven by rising sleep apnea prevalence and home healthcare demand. Automatic CPAP systems will lead by operation type with a 70% share due to their ease of use and adaptive technology. These segments highlight high-value opportunities for manufacturers focusing on patient-centric and smart respiratory solutions.
The CPAP Devices segment is projected to hold a commanding 65% market share in 2025, outpacing CPAP Accessories which are expected to account for the remaining 35%. This dominance is primarily due to the critical role that CPAP devices play in treating obstructive sleep apnea (OSA)-a condition that is rising globally owing to aging populations, increasing obesity rates, and lifestyle factors.
These devices deliver a constant flow of pressurized air to keep airways open during sleep, providing substantial relief to patients suffering from OSA. Manufacturers like ResMed, Philips Respironics, and Fisher & Paykel Healthcare lead this space by introducing advanced, compact, and travel-friendly CPAP devices equipped with features such as humidification, wireless connectivity, and mobile app integrations for therapy tracking.
The growing preference for at-home sleep therapy, coupled with reimbursement support in developed markets, is further boosting device adoption. Additionally, the emergence of portable and auto-adjusting CPAP machines meets the needs of an increasingly mobile and tech-savvy patient base, ensuring that CPAP Devices will remain the top revenue-generating segment in the market.
Automatic CPAP systems are expected to capture a substantial 70% market share by 2025, outperforming the Manual CPAP segment, which will hold the remaining 30%. The rise in demand for automatic variants stems from their ability to adjust air pressure dynamically based on the patient’s breathing patterns throughout the sleep cycle, ensuring optimal therapy without user intervention.
These auto-titrating systems offer superior patient comfort and compliance compared to manual devices, which require fixed pressure settings and frequent recalibration by clinicians. Major players such as ResMed and Philips have introduced smart automatic CPAP devices that integrate advanced sensors, cloud-based data storage, and Bluetooth connectivity to deliver personalized treatment regimens.
The shift towards home-based sleep apnea management and the need for user-friendly solutions have accelerated the adoption of automatic CPAP devices, particularly in developed regions. Furthermore, increasing physician and patient awareness about the benefits of adaptive pressure systems contributes to this segment’s expansion. As technology continues to evolve, the Automatic CPAP segment remains a prime investment opportunity, offering higher margins and sustained market growth potential for manufacturers and suppliers.
Continuous positive airway pressure is in high demand, driven by several factors, including the growing prevalence of sleep apnea, increased awareness about sleep disorders, and the increasing demand for home-based treatment options.
The market is also being influenced by the growing demand for connected devices, which allow patients to monitor their sleep patterns and provide real-time data to healthcare providers.
The CPAP market is also driven by the increasing focus on patient comfort, with manufacturers incorporating features such as heated humidifiers and noise-reducing technology into their devices.
Increasing focus on patient comfort, as manufacturers are incorporating features such as heated humidifiers and noise-reducing technology into their devices presents potential opportunities for the market. The rise of telemedicine and telehealth has created new opportunities for remote patient monitoring and remote diagnoses, which can benefit the CPAP market.
Continuous positive airway pressure in the Asia Pacific region is experiencing rapid growth due to the increasing prevalence of sleep apnea and the increasing awareness about sleep disorders. The growing demand for home-based sleep apnea treatments and the increasing focus on patient comfort are also contributing to the growth of the CPAP market in the Asia Pacific region.
The increasing number of sleep clinics and sleep centers in the region is providing patients with easier access to CPAP therapy. The Asia Pacific CPAP market is expected to continue growing in the coming years, due to the increasing demand for sleep apnea treatment and the increasing focus on patient comfort.
The most lucrative end-use area in the continuous positive airway pressure (CPAP) market is likely to be home care settings. The increasing demand for home-based sleep apnea treatments and the growing trend towards patient-centered care are driving the demand for CPAP devices for home use.
Patients are increasingly seeking the convenience and comfort of being able to manage their sleep apnea therapy from the comfort of their own homes, and the growing availability of compact and portable CPAP devices is making this option more accessible.
The increasing focus on remote patient monitoring and telehealth has created new opportunities for the home-based CPAP market, as patients are able to use connected devices to monitor their sleep patterns and share real-time data with their healthcare providers. The growing demand for home-based CPAP therapy is expected to continue driving growth in the market in the coming years.
The CPAP market is highly competitive, with a large number of established players and new entrants vying for market share and customer loyalty.
Recent Developments:
Continuous positive airway pressure machines are typically utilized as assistive/supportive and preventive devices to treat patients of SAHS, acute asthma, cardiogenic pulmonary edema, congestive heart failure, chronic lung disease (CLD), cystic fibrosis, and COPD treatment. Of late, they are finding application in providing breathing assistance, rather, as a potential substitute for ventilator.
After the FDA’s recent emergency policy, various alternative respiratory devices emerged to be used as potential replacers for lifesaving ventilators. In light of shortages of ventilators that quickly began to influence the scenario at hospitals and emergency response centers during the novel coronavirus pandemic, CPAP devices started witnessing greater preference among others in the category.
However, as suggested by the American Society of Anesthesiologists’ guidance, utilization of such non-invasive respiratory devices must be subject to additional caution as it is often prone to dispersal of unfiltered droplets, eventually adding to the air-borne infection of virus.
Although the increasingly significant role of CPAP in providing rapid and cost-competitive treatment to COVID-19 patients is placing it much beyond its traditional areas of application, it becomes imperative to comprehend its actual scope of application and viability in these times.
Looking at the existing shortcomings of CPAP in effectively compensating for the undersupply of ventilators, it is of paramount importance to keep abreast of the latest innovations entering the CPAP space.
With industry behemoths such as GE Healthcare and Medtronic ramping up their ventilator production, the latter expects over 40% rise in its global production levels in the near future.
The former, on the other side, announced the plan of establishment of its multiple manufacturing facilities in the following years. ResMed also recently revealed its significant production capacity expansion, in collaboration with Tesla, during the past three months.
Future Market Insights (FMI), in this pipeline report, provides a deep-dive analysis of the global CPAP market. In addition to offering a detailed assessment of the key market dynamics and the forthcoming opportunities facing potential investors, the report predominantly covers the impact of novel coronavirus outbreak on the various CPAP market elements over the course of near future.
CPAP machines are being effectively used in treating COVID-19 patients with less severe issues with breathing. However, experts opine that these CPAP machines are themselves capable of aiding the spread of infection irrespective of at hospitals or home care settings.
Aerosolization of the coronavirus due to CPAP masks remains a major concern, which adds to the scepticism regarding adoption of CPAP as a substitute for ventilator. Research shows that face masks that are used for CPAP or bilevel PAP (BiPAP) tend to let air escape, along with the virus, eventually infecting others in the vicinity, including healthcare providers, and patients.
The most commonly observed side effects of CPAP include the claustrophobic feeling under masks, runny nose, nasal congestion, and a greater risk of contamination due to aerosol generation. These factors prevail as key challenges to wider recommendation of CPAP devices.
Moreover, the paucity of patient compliance during diagnosis and treatment will remain a hindrance to broader adoption of CPAP units. Expensive price point of respiratory assistance devices, CPAP therapy administration and associated products also stands as an impediment to skyrocketing demand.
However, the market is recently witnessing an influx of novel innovations that decently attempt to present competitively priced products with a better comfort quotient.
Rapid turnaround and mass production compatibility are currently the top parameters on the minds of these innovators to cater to respiratory assistance needs of COVID-19 patients at the earliest.
| Report Attributes | Details |
|---|---|
| Market Size (2025E) | USD 561.8 million |
| Projected Market Size (2035F) | USD 1 billion |
| CAGR (2025 to 2035) | 6.0% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Quantitative Units | USD million/billion for value and thousand units for volume |
| Product Types Analyzed (Segment 1) | CPAP Devices, CPAP Accessories |
| Operation Types Analyzed (Segment 2) | Manual, Automatic |
| Patient Types Analyzed (Segment 3) | Paediatric, Adult |
| End-Use Areas Analyzed (Segment 4) | Hospitals, Home Care Settings, Private Clinics |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, China, Asia Pacific (Excluding China), Middle East & Africa |
| Countries Covered | United States, Canada, Mexico, Brazil, Argentina, Germany, United Kingdom, France, Italy, Spain, China, Japan, South Korea, India, Australia, Thailand, Vietnam, South Africa, Saudi Arabia, UAE |
| Key Players in CPAP Market | ResMed, Koninklijke Philips, Medtronic, Armstrong Medical Inc., Smiths Medical, Cardinal Health, Apex Medical Corp., Koike Medical, DeVilbiss Healthcare LLC, Beijing Dehaier Medical Technology, Teijin Pharma, BMC Medical, Fosun Pharma, 3B Medical Inc., Fisher & Phillips LLP, Invacare Corporation |
| Additional Attributes | Dollar sales, share, rising home healthcare demand, technological advancements in auto-adjusting CPAP devices, patient comfort features, telemedicine integration, growing sleep apnea awareness among elderly and obese populations |
This FMI study, in addition to providing some solid actionable insights on the increasingly significant role of CPAP machines in combating the coronavirus crisis, offers information on the latest developments of market leaders in this regard.
Some of the prominent companies active in the global CPAP market landscape that are profiled in the report include ResMed, Koninklijke Philips, Medtronic, Armstrong Medical Inc., Smiths Medical, Cardinal Health, Apex Medical Corp., Koike Medical, DeVilbiss Healthcare LLC, Beijing Dehaier Medical Technology, Teijin Pharma, BMC Medical, Fosun Pharma, 3B Medical, Inc., Fisher & Phillips LLP, and Invacare Corporation.
The global market landscape continues to reflect a fragmented nature, yet continues to witness primacy of leading international players. Product features, competitive pricing structure, and reliability act as the key differentiating touchpoints for companies competing in the market.
Recently, a British Formula 1 engine manufacturer - Mercedes-AMG High Performance Powertrains (Northamptonshire), developed an efficient breathing aid in form of a CPAP unit to respond to the expected rise in COVID-19 patients with breathing difficulties. This device has been developed through reverse engineering one of their existing devices, and it definitely eliminates the need for a ventilator.
Explore Therapeutic Device Insights
Continuous Positive Airway Pressure (CPAP) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
